1. Market Research
  2. > Healthcare Market Trends

Poland Medical Sector Report - 2013

  • April 2014
  • 26 pages
  • Emerging Markets Direct Media Holdings
Report ID: 3307067

Summary

Table of Contents

This report analyzes the profile and legal framework of the medical sector in Poland, as well as trends and corporate developments of 2013. Industry players discussed in the report include companies such as Bupa, Polpharma, and the state-owned CF Cefarm, among others.



Poland's health care system has experienced a major transformation since 1999, moving from a centralized budget-funded structure to a decentralized system funded by mandatory health insurance. The country's healthcare system is still undergoing reforms, with the latest being a supplementary health insurance bill that is expected to be ready by the end of 2013.



Employment in the Polish medical sector kept rising in 2011 and is projected to continue rising in the next few years. Yet, on a regional level, Poland has a poor showing in terms of physicians per 1,000 inhabitants. The number of medical graduates per 100,000 people in Poland is below the average for OECD countries; the same goes for nursing graduates. Regarding the sector's capacity, the annual growth in the number of general hospitals eased to 2.4% in 2011 from 5.4% in 2010, while the number of hospital beds dropped by 0.9% on the year to 178,907 as of end-2011, according to data from the Polish statistics office. The rate of increase in outpatient healthcare units accelerated in 2011, with private facilities boosting their share of the total to 86%. Espicom estimates that Poland has the second-lowest hospital bed rate in Central and Eastern Europe, standing at 4.8 in 2013. The country has the third-highest number of hospitals in the region.



Key Points:



oIn corporate news, international healthcare group Bupa completed the acquisition of LUX MED, the largest private healthcare provider in Poland. Leading pharmaceutical manufacturer Polpharma sold its OTC antithrombotic drug Polocard to US-based Pfizer. And Polish firms Sepo and Hasco-Lek were shortlisted to acquire an 85% stake in the state-owned pharmaceutical distribution firm Centrala Farmaceutyczna Cefarm (CF Cefarm).



oPoland's total spending on health accounted for 6.7% of the country's economic output in 2011, down from 7% in 2010, and was below that of its CEE peers - Hungary and the Czech Republic with 7.7% and 7.4%, respectively.



oPublic funds account for 71.2% of Poland's total health spending. Health expenditure per capita in Poland stood at USD 899 in 2011, the lowest among the so-called Vesegrad countries, according to WHO data.



oThe value of the Polish private health care market grew by 4.4% y/y to PLN 33.8bn (EUR 8.1bn) in 2012 and is forecast to expand at an average annual rate of 5% by 2015. The sector's growth eased from 6.8% in 2011 mainly due to slower growth in the category "patients' spending on healthcare products." The Polish private health care market is forecast to reach a value of PLN 39bn in 2015.



oSupplementary health insurance will remain the fastest-growing segment in the next two years. Medical subscriptions will be the second fastest-growing segment.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Minimally invasive mitral valve repair and replacement procedures. Combined report. European reimbursement report

  • $ 19250
  • Industry report
  • April 2017
  • by Med Tech Reimbursement Consulting

Report presents summary of the reimbursement situation in Europe for all developed or currently under development minimally invasive (transapical approach via mini-thoracotomy) and transcatheter mitral ...

2017 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 12800
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.